Laddar...
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
Established therapies for diabetic nephropathy (dNP) delay but do not prevent its progression. The shortage of established therapies may reflect the inability to target the tubular compartment. The chemical chaperone tauroursodeoxycholic acid (TUDCA) ameliorates maladaptive endoplasmic reticulum (ER...
Sparad:
| I publikationen: | J Am Soc Nephrol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society of Nephrology
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661274/ https://ncbi.nlm.nih.gov/pubmed/28696246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016101123 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|